Intravenous enzyme replacement therapy: better in home or hospital?

British Journal of Nursing : BJN
A MilliganA Mehta

Abstract

This article evaluates satisfaction with enzyme replacement therapy (ERT) at home and at hospital in adult patients with Fabry and Gaucher diseases. A questionnaire was developed and sent to 34 patients with Fabry disease who were receiving ERT with agalsidase alfa (Replagal) and to 49 patients with type I Gaucher disease who were receiving ERT with glucocerebrosidase (Cerezyme). Of the 45 returned questionnaires, 20 were from patients with Fabry disease and 25 from patients with Gaucher disease. Hospital treatment visits were reported as stressful by 18 patients (40%), whereas only 4 (9%) patients reported that home therapy was stressful. Both groups of patients adjusted well to receiving home-based therapy. Nearly all of the patients with Fabry disease (19 patients, 95%) and Gaucher disease (21 patients, 84%) preferred home-based therapy. Treatment in the home was reported as more comfortable, less stressful, more effective and had less impact on family life. Only 4 (9%) patients chose to continue receiving infusions in hospital. The majority of patients with Fabry disease and Gaucher disease found home-based therapy to be more convenient and less stressful than hospital-based therapy.

References

Jan 26, 1999·JAMA : the Journal of the American Medical Association·P J MeikleW F Carey
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·R SchiffmannR O Brady
Jun 21, 2001·JAMA : the Journal of the American Medical Association·R SchiffmannR O Brady
Mar 14, 2002·Expert Opinion on Biological Therapy·Gregory M Pastores, Ravi Thadhani
Sep 27, 2002·QJM : Monthly Journal of the Association of Physicians·A Mehta
Jan 31, 2003·Expert Opinion on Investigational Drugs·Gregory M Pastores, Natalie L Barnett
Jan 18, 1965·Biochemical and Biophysical Research Communications·R O BRADYD SHAPIRO
Feb 3, 2005·British Journal of Haematology·Ashok Vellodi
Apr 9, 2005·British Journal of Haematology·Marina Jmoudiak, Anthony H Futerman

❮ Previous
Next ❯

Citations

Sep 24, 2009·Biologics : Targets & Therapy·Deborah Elstein, Ari Zimran
May 10, 2011·Drug Design, Development and Therapy·Uma Ramaswami
Nov 1, 2011·European Journal of Pediatrics·Joseph MuenzerPaul Harmatz
Nov 9, 2011·Orphanet Journal of Rare Diseases·Maurizio ScarpaUNKNOWN Hunter Syndrome Europena Expert Council
Jan 22, 2013·Molecular Genetics and Metabolism·B E SmidG E Linthorst
Mar 23, 2010·La Presse médicale·Nadia BelmatougUNKNOWN Comité d'Evaluation du Traitement de la maladie de Gaucher
Nov 13, 2010·European Journal of Clinical Investigation·Julian F GuestEinar Svarstad
Feb 9, 2011·European Journal of Clinical Investigation·Julian F GuestAnna Zampetti
Dec 1, 2010·Acta Paediatrica·U RamaswamiM Beck
Jun 17, 2015·Orphanet Journal of Rare Diseases·Maarten ArendsMarieke Biegstraaten
Jul 30, 2014·Genetics and Molecular Biology·Roberto GiuglianiHernán Amartino
Jul 11, 2018·American Journal of Hematology·Ari ZimranJeff Szer
Sep 25, 2018·Journal of Managed Care & Specialty Pharmacy·Luba NalysnykAlexandra Ward
May 28, 2008·Acta Paediatrica·Atul Mehta
Jul 17, 2008·Expert Opinion on Pharmacotherapy·Neal J Weinreb
Sep 12, 2009·Expert Opinion on Pharmacotherapy·Carla E M HollakJohannes M F G Aerts
Sep 1, 2010·Expert Review of Endocrinology & Metabolism·Atul Mehta
Mar 26, 2008·British Journal of Nursing : BJN·Derryalynn A HughesAtul Mehta
Jul 22, 2010·British Journal of Nursing : BJN·Rossella PariniMiriam Rigoldi
Feb 1, 2008·NDT Plus·Frédéric BarbeyAndreas Schwarting
May 4, 2017·Orphanet Journal of Rare Diseases·Joseph MuenzerDavid A H Whiteman
Feb 10, 2021·Fortschritte der Neurologie-Psychiatrie·Andreas HahnBenedikt Schoser
Apr 12, 2018·Health Psychology and Behavioral Medicine·Eduardo Remor, Antonio Baldellou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.